SNTI Senti Biosciences Holdings, Inc.
Senti Biosciences Holdings, Inc. (SNTI) is expected to report earnings on February 15, 2027, after the market close. The stock has had a Post-Earnings Announcement Drift (PEAD) of +1167.9% since its last earnings release on November 16, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Senti Biosciences Holdings, Inc.
Senti Biosciences Inc. is a biotechnology company developing next-generation cell and gene therapies using its proprietary gene circuit platform. Senti Biosciences Inc., formerly known as Dynamics Special Purpose Corp., is based in SOUTH SAN FRANCISCO, Calif.
Sector
Healthcare
Industry
Biotechnology
Charts powered in part by Lightweight Charts™ by TradingView.